Medicen: A world-class «competitiveness cluster» in the Paris region incorporating a neuroscience «subcluster»;Medicen Paris Région, pôle de compétitivité mondial et recherche en neuroscience

Medecine/Sciences

Volumn 23, Issue 4, 2007, Pages 435-439

  Canet, Emmanuel ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CARCINOEMBRYONIC ANTIGEN;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COMPETITION; DEGENERATIVE DISEASE; FRANCE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; MEDICAL RESEARCH; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEOMICS; RHESUS MONKEY;

MACACA MULATTA;

EID: 34247214439     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007234435     Document Type: Article

References (13)

1. Pour un écosystème de la croissance. Paris : Rapport au premier ministre, Blanc C. 2005.
2. www.medicen.org
3. Dhenain M, Lehéricy S, Duyckaerts C. Le diagnostic : de la neuropathologie à l'imagerie cérébrale. Med Sci (Paris) 2002 ; 18 : 697-708.
4. Hardy J, Duff K, Hardy K, et al. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1998 ; 1 : 355-8.
5. Poduslo JF, Curran GL, Peterson JA, et al. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Biochemistry 2004 ; 43 : 6064-75.
6. Higuchi M, Iwata N, Matsuba Y, et al. (19)F and (1)H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 2005 ; 8 : 527-33.
7. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003 ; 2 : 605-13.
8. Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg 2005 ; 107 3 : 165-73.
9. Delatour B, Le Cudennec C, El Tannir-El Tayara N, Dhenain M. Transgenic models of Alzheimer's pathology: success and cavaet. In : Progress in Alzheimer's disease research. Paris : Éditions Nova, 2007 (sous presse).
10. Gearing M, Rebeck GW, Hyman BT, et al. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci USA 1994 ; 91 : 9382-6.
11. Schultz C, Hubbard GB, Rub U, Braak H. Age-related progression of tau pathology in brains of baboons. Neurobiol Aging 2000 ; 21 : 905-12.
12. Deglon N, Hantraye P. Viral vectors as tools to model and treat neurodegenerative disorders. J Gene Med 2005 ; 7 : 530-9.
13. Albert M, DeCarli C, DeKosky S, et al. The use of MRI and PET for clinical diagnosis of dementia and investigation of cognitive impairment: a consensus report. Report of the Neuroimaging Work Group of the Alzheimer's Association, 2005.